Investigating the Thioredoxin and Glutathione Systems’ Response in Lymphoma Cells after Treatment with [Au(d2pype)2]Cl
Lymphoma is a blood cancer comprising various subtypes. Although effective therapies are available, some patients fail to respond to treatment and can suffer from side effects. Antioxidant systems, especially the thioredoxin (Trx) and glutathione (GSH) systems, are known to enhance cancer cell survi...
Main Authors: | Sicong Wang, Yaoying Lu, Kyra Woods, Giovanna Di Trapani, Kathryn F. Tonissen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/10/1/104 |
Similar Items
-
Expanding the armory for treating lymphoma: Targeting redox cellular status through thioredoxin reductase inhibition
by: Sicong Wang, et al.
Published: (2022-03-01) -
Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment
by: Erin Clapper, et al.
Published: (2020-03-01) -
The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies
by: Morana Jaganjac, et al.
Published: (2020-11-01) -
Kinetic Effects of Transferrin-Conjugated Gold Nanoparticles on the Antioxidant Glutathione-Thioredoxin Pathway
by: Sonia Sebastian, et al.
Published: (2023-08-01) -
Transcriptional changes of proteins of the thioredoxin and glutathione systems in Acanthamoeba spp. under oxidative stress – an RNA approach
by: Köhsler Martina, et al.
Published: (2022-01-01)